ARTICLES|ONLINE FIRST Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial René Post, Menno R Germans, Maud A Tjerkstra, et al. Lancet Published:December 21, 2020 DOI:https://doi.org/10.1016/S0140-6736(20)32518-6 Summary Background In patients with aneurysmal subarachnoid haemorrhage, short-term antifibrinolytic therapy with tranexamic acid has been shown to reduce the risk of rebleeding. However, whether this...

ORIGINAL ARTICLE Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, et al N Engl J Med 2021; 384:403-416DOI: 10.1056/NEJMoa2035389 Abstract BACKGROUND Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full...

Nebulised Heparin for Patients with ARDS Mechanical ventilation in the ICU for 48 hours or longer is known to be associated with ARDS, which could be present either when ventilatory support is initiated or develop afterwards, typically during the first five days. ARDS affects approximately 23% of mechanically ventilated, critically ill patients and has a mortality of nearly 46%. Patients on prolonged mechanical ventilation and ARDS are at risk of impaired physical func...

CORRESPONDENCE Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 Min-Chul Kim, Chunguang Cui, Kyeong-Ryeol Shin, et al N Engl J Med January 27, 2021DOI: 10.1056/NEJMc2027040 TO THE EDITOR: The duration of transmissibility of coronavirus disease 2019 (Covid-19) and the associated level of contagion have been uncertain. We cultured severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in serial respiratory samples obtained from h...

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial Barry Dixon, Roger J Smith, Duncan J Campbell, et al Lancet Respir Med Published:January 22, 2021 DOI:https://doi.org/10.1016/S2213-2600(20)30470-7 Summary Background Mechanical ventilation in intensive care for 48 h or longer is associated with the acute respiratory distress syndrome (ARDS), which ...

Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery Lancet 2021; 397: 387–97 Summary Background 80% of individuals with cancer will require a surgical procedure, yet little comparative data exist on early outcomes in low-income and middle-income countries (LM...

ICU Management & Practice, Volume 20 - Issue 4, 2020 The Seraph® 100: Evidence and Perspectives An overview of the clinical application and future perspective of the Seraph® 100 haemoperfusion in critically ill patients with sepsis. Background Over the last few decades, sepsis has been spreading worldwide to such an extent that it has been declared global health priority by the World Health Organization (Reinhart et al. 2017). Sepsis is an old disease...

Original Contribution October 8, 2003 Safety of Patients Isolated for Infection Control Henry Thomas Stelfox, David W. Bates, Donald A. Redelmeier, et al JAMA 2003;290(14):1899-1905. doi:10.1001/jama.290.14.1899 Abstract Context 背景 Hospital infection control policies that use patient isolation prevent nosocomial transmission of infectious diseases, but may inadvertently lead to patient neglect and errors. 医院的感染控制措施要求对患者进行隔离以...

ICU Management & Practice, Volume 20 - Issue 4, 2020 Biomarkers and Their Impact in ICU Patient Outcomes The laboratory plays a critical role in ensuring optimal outcomes for ICU patients. Several biomarkers are valuable in this context and can help clinicians achieve improved patient outcomes and decreased expenses for healthcare. Improving both in-ICU and post-ICU clinical outcomes often depends on actions taken much sooner in a patient’s pathway durin...

CORRESPONDENCE Renal replacement therapy in acute kidney injury – Authors' reply Stéphane Gaudry, David Hajage, Agnès Dechartres, et al Lancet 2020; 396: 1975-1976 DOI:https://doi.org/10.1016/S0140-6736(20)32673-8 We disagree with Vincenzo Sepe and colleagues' comment about the timing and prescription of renal replacement therapy (RRT). In the randomised controlled trials included in our systematic review and individual patient data meta-analysis,1 the protoco...